GO:0006772 thiamine metabolic process: Vitamin B1 Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006772 thiamine metabolic process describes all chemical reactions and pathways involving thiamine (vitamin B1), a water-soluble vitamin essential for mitochondrial energy metabolism.
• Thiamine is converted to its active coenzyme form, thiamine pyrophosphate (TPP), which is required by enzymes such as pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase.
• Defects in thiamine transport and metabolism cause human disease, including thiamine-responsive megaloblastic anemia, Wernicke encephalopathy, and beriberi.
• Thiamine bioavailability varies widely among foods; animal-derived foods generally provide higher bioavailability than plant sources.
• Thiamine-binding proteins and transporters regulate cellular thiamine homeostasis, and their dysfunction is linked to metabolic and neurological disorders.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of thiamine metabolic genes in human cells and animal models.
Description
Thiamine (vitamin B1) is a water-soluble vitamin that is indispensable for carbohydrate metabolism and mitochondrial energy production. The Gene Ontology term GO:0006772, thiamine metabolic process, encompasses the chemical reactions and pathways involving thiamine, including its uptake, phosphorylation, coenzyme synthesis, and degradation. This process is conserved across prokaryotes, plants, and animals, and its disruption leads to severe metabolic and neurological phenotypes. Researchers study thiamine metabolism to understand mitochondrial dysfunction, neurodegenerative disease, and metabolic disorders, as well as to improve nutritional content in crops and animal feed. The term is also central to interpreting genetic variants in thiamine transporters and enzymes identified by clinical genomics. Because thiamine cannot be synthesized by humans, its bioavailability from diet and its cellular metabolism are critical determinants of health.
thiamine metabolic process At A Glance
| GO ID | GO:0006772 |
|---|---|
| GO term | thiamine metabolic process |
| Ontology | biological_process |
| Synonym | thiamine metabolism; thiamin metabolic process; thiamin metabolism; vitamin B1 metabolic process; vitamin B1 metabolism |
| Major function | Conversion of thiamine to thiamine pyrophosphate (TPP) and other derivatives for use as enzyme cofactors in energy metabolism |
| Key cofactor | Thiamine pyrophosphate (TPP), the active form of vitamin B1 |
| Associated enzymes | Thiamine pyrophosphokinase, thiamine phosphate phosphatase, transketolase, pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase |
| Associated transporters | SLC19A2 (THTR1), SLC19A3 (THTR2), SLC25A19 (mitochondrial thiamine pyrophosphate carrier) |
| Disease relevance | Thiamine deficiency causes beriberi and Wernicke-Korsakoff syndrome; genetic defects cause thiamine-responsive megaloblastic anemia and Amish microcephaly |
What Is GO:0006772?
GO:0006772 thiamine metabolic process is defined as the chemical reactions and pathways involving thiamine (vitamin B1), a water-soluble vitamin present in fresh vegetables and meats, especially liver. This includes the conversion of thiamine to its active coenzyme form thiamine pyrophosphate (TPP), the interconversion of thiamine derivatives, and the degradation of thiamine and its phosphorylated forms. The term covers both the biosynthesis of thiamine in organisms that produce it and the metabolic transformations of dietary thiamine in animals that require it as a vitamin.
Why Is thiamine metabolic process Important in Cell Biology?
Thiamine metabolic process is essential for life because thiamine pyrophosphate (TPP) serves as an indispensable cofactor for several enzymes in central carbon metabolism, including pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and transketolase. These enzymes link glycolysis, the tricarboxylic acid cycle, and the pentose phosphate pathway, and their dysfunction leads to energy failure, oxidative stress, and neurodegeneration. In addition, thiamine metabolism is a target for crop biofortification to combat hidden hunger in human populations and for improving feed efficiency in livestock. Understanding the genes and regulatory mechanisms of thiamine metabolism is therefore relevant to human health, agriculture, and biotechnology.
• Thiamine deficiency causes beriberi, a disease characterized by peripheral neuropathy and heart failure, and Wernicke-Korsakoff syndrome, a neurological emergency.
• Mutations in SLC19A2 cause thiamine-responsive megaloblastic anemia syndrome, which can be treated with high-dose thiamine.
• Mutations in SLC19A3 cause biotin-responsive basal ganglia disease, a condition that may respond to thiamine supplementation.
• Thiamine metabolism is critical for mitochondrial energy production, and its impairment contributes to lactic acidosis and neurodegeneration.
• Thiamine bioavailability from plant foods is lower than from animal foods, which has implications for dietary recommendations.
• Thiamine-binding proteins modulate thiamine availability and may serve as therapeutic targets.
• In dairy cows, thiamine status affects rumen fermentation and animal health, making it relevant to veterinary nutrition.
• Crop biofortification with thiamine is a strategy to improve human nutrition in populations relying on staple crops.
• Thiamine pyrophosphate metabolism is being engineered to enhance crop yield and quality.
• Studying thiamine metabolic genes with CRISPR models can reveal causal roles in disease and identify therapeutic targets.
What Happens During thiamine metabolic process?
Thiamine uptake and transport
In simple terms: Cells take up vitamin B1 from the environment or bloodstream using specialized transporter proteins.
Thiamine enters cells primarily through specific transporters, including SLC19A2 (THTR1) and SLC19A3 (THTR2), which are expressed in the intestine, kidney, and other tissues. In humans, dietary thiamine is absorbed in the small intestine, and its bioavailability depends on the food matrix, with animal-derived foods generally providing higher bioavailability than plant foods. Inside cells, thiamine is transported into mitochondria by the mitochondrial thiamine pyrophosphate carrier SLC25A19. Thiamine-binding proteins may also facilitate its transport and storage.
Phosphorylation to thiamine pyrophosphate (TPP)
In simple terms: Once inside the cell, vitamin B1 is converted into its active coenzyme form by adding phosphate groups.
Thiamine is phosphorylated to thiamine monophosphate (TMP) and then to thiamine pyrophosphate (TPP) by thiamine pyrophosphokinase (TPK1). TPP is the biologically active form that serves as a cofactor for enzymes involved in carbohydrate metabolism. The interconversion of thiamine phosphates is regulated by specific phosphatases, and the balance between free thiamine and TPP is critical for cellular function.
TPP-dependent enzyme reactions
In simple terms: The active form of vitamin B1 helps enzymes break down sugars and amino acids to produce energy.
TPP is an essential cofactor for pyruvate dehydrogenase (PDH), alpha-ketoglutarate dehydrogenase (OGDH), branched-chain alpha-ketoacid dehydrogenase (BCKDH), and transketolase (TKT). PDH converts pyruvate to acetyl-CoA, linking glycolysis to the TCA cycle; OGDH functions in the TCA cycle; BCKDH catabolizes branched-chain amino acids; and TKT operates in the pentose phosphate pathway. These reactions are central to mitochondrial energy metabolism and the generation of reducing equivalents.
Thiamine salvage and degradation
In simple terms: Cells can recycle and break down vitamin B1 derivatives to maintain proper levels.
Thiamine and its phosphorylated derivatives can be dephosphorylated by thiamine phosphate phosphatases to free thiamine, which can be re-phosphorylated or exported. Degradation pathways for thiamine involve oxidation and hydrolysis, producing inactive metabolites that are excreted. The salvage of thiamine from dietary sources and from intracellular turnover ensures a steady supply of TPP for metabolic enzymes.
Regulation of thiamine homeostasis
In simple terms: Cells adjust the amount of vitamin B1 they absorb and convert based on need.
Thiamine homeostasis is regulated at the levels of transport, phosphorylation, and enzyme expression. For example, expression of thiamine transporters can be modulated by thiamine availability, and TPK1 activity is subject to feedback inhibition by TPP. In plants and microorganisms, thiamine biosynthesis is regulated by riboswitches and transcriptional regulators in response to thiamine levels. In animals, hormonal and nutritional signals influence thiamine status, but the precise mechanisms are still being elucidated.
Key Genes Involved in GO:0006772 thiamine metabolic process
The following genes and proteins are central to thiamine metabolic process, including transporters, kinases, phosphatases, and TPP-dependent enzymes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC19A2 | Thiamine transporter 1 (THTR1); mediates cellular uptake of thiamine | Mutations cause thiamine-responsive megaloblastic anemia; target for studying transport defects |
| SLC19A3 | Thiamine transporter 2 (THTR2); high-affinity thiamine uptake in brain and other tissues | Mutations cause biotin-responsive basal ganglia disease; models for neurodegeneration |
| SLC25A19 | Mitochondrial thiamine pyrophosphate carrier; imports TPP into mitochondria | Defects cause Amish microcephaly and mitochondrial thiamine metabolism disorders |
| TPK1 | Thiamine pyrophosphokinase; converts thiamine to TPP | Key enzyme for TPP synthesis; knockout models show impaired energy metabolism |
| TPP1 | Thiamine triphosphatase; hydrolyzes thiamine triphosphate | Regulates thiamine phosphate levels; potential role in neurological function |
| PDHA1 | Pyruvate dehydrogenase E1 alpha subunit; requires TPP as cofactor | TPP-dependent enzyme; mutations cause pyruvate dehydrogenase deficiency |
| PDHB | Pyruvate dehydrogenase E1 beta subunit; TPP-binding | Component of PDH complex; relevant to mitochondrial energy metabolism |
| OGDH | Alpha-ketoglutarate dehydrogenase; TPP-dependent TCA cycle enzyme | Dysfunction linked to neurodegeneration and metabolic disorders |
| DLD | Dihydrolipoamide dehydrogenase; component of PDH and OGDH complexes | TPP-related enzyme; mutations cause E3 deficiency |
| BCKDHA | Branched-chain alpha-ketoacid dehydrogenase E1 alpha; TPP-dependent | Maple syrup urine disease; TPP cofactor required |
| TKT | Transketolase; TPP-dependent enzyme in pentose phosphate pathway | Reduced activity in thiamine deficiency; marker of thiamine status |
| THTPA | Thiamine triphosphatase; degrades thiamine triphosphate | Regulates thiamine triphosphate levels; potential neurological role |
| TPK1 | Thiamine pyrophosphokinase; also known as thiamin pyrophosphokinase | Overexpression or knockout models to study TPP synthesis |
| SLC19A1 | Reduced folate carrier; can also transport thiamine monophosphate | Broad substrate specificity; relevant to vitamin transport |
| THTR1 | Thiamine transporter 1; encoded by SLC19A2 | Alias for SLC19A2; used in transport studies |
| THTR2 | Thiamine transporter 2; encoded by SLC19A3 | Alias for SLC19A3; brain-specific expression |
How Is thiamine metabolic process Regulated?
Thiamine metabolic process is regulated at multiple levels. In humans, thiamine transporters SLC19A2 and SLC19A3 are subject to regulation by thiamine availability and possibly by transcriptional factors, although the exact mechanisms remain incompletely understood. The enzyme TPK1, which synthesizes TPP, is feedback-inhibited by its product TPP, ensuring that TPP levels are maintained within a narrow range. In plants and bacteria, thiamine biosynthesis is controlled by riboswitches and transcriptional regulators that respond to thiamine pyrophosphate concentrations. In dairy cows, thiamine status is influenced by diet and rumen microbial synthesis, and supplementation can modulate metabolic pathways. Additionally, thiamine-binding proteins may sequester thiamine and regulate its availability. Overall, regulation ensures adequate TPP for mitochondrial enzymes while preventing toxicity from excess thiamine phosphates.
thiamine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC19A2 | Thiamine-responsive megaloblastic anemia syndrome | Knockout HEK293 or patient-derived iPSCs; thiamine supplementation rescue |
| SLC19A3 | Biotin-responsive basal ganglia disease | Knockout neuronal cell lines; thiamine transport assays |
| SLC25A19 | Amish microcephaly; mitochondrial TPP deficiency | Knockout mouse models; mitochondrial function assays |
| TPK1 | Thiamine pyrophosphokinase deficiency; neurological symptoms | Point-mutation knock-in in cell lines; TPP level measurement |
| PDHA1 | Pyruvate dehydrogenase deficiency; lactic acidosis | Knockout or point-mutation models; metabolic flux analysis |
Thiamine deficiency disorders: beriberi and Wernicke-Korsakoff syndrome
Dietary thiamine deficiency causes beriberi, characterized by peripheral neuropathy, muscle weakness, and heart failure, as well as Wernicke-Korsakoff syndrome, a neurological disorder with confusion, ataxia, and memory loss. These conditions are more common in populations consuming polished rice or in individuals with chronic alcohol use, which impairs thiamine absorption and storage. Thiamine supplementation is an effective treatment, highlighting the importance of thiamine metabolic process in human health.
Genetic defects in thiamine transport and metabolism
Mutations in SLC19A2 cause thiamine-responsive megaloblastic anemia syndrome, which presents with anemia, diabetes, and deafness and responds to high-dose thiamine. Mutations in SLC19A3 cause biotin-responsive basal ganglia disease, a condition that can be treated with thiamine and biotin. Defects in SLC25A19 cause Amish microcephaly and severe neurological impairment. These disorders demonstrate that specific genes in thiamine metabolic process are critical for normal development and function.
Thiamine metabolism in mitochondrial dysfunction and neurodegeneration
Thiamine pyrophosphate is essential for mitochondrial energy metabolism, and its deficiency leads to impaired oxidative phosphorylation, lactic acidosis, and oxidative stress. Neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease have been associated with altered thiamine status, although causality is not fully established. TPP-dependent enzymes, including PDH and OGDH, are vulnerable to oxidative damage, and their dysfunction contributes to neuronal death. Studying thiamine metabolic genes in cell and animal models can clarify these mechanisms.
Thiamine metabolism in cancer and metabolic reprogramming
Cancer cells often reprogram metabolism to support rapid proliferation, and thiamine-dependent enzymes such as transketolase are important for nucleotide synthesis via the pentose phosphate pathway. Targeting thiamine metabolism has been proposed as a therapeutic strategy, but further research is needed to validate specific targets. The role of thiamine transporters in cancer drug resistance is also an active area of investigation.
From thiamine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC19A2 impair thiamine uptake and cause anemia? | CRISPR knockout of SLC19A2 in erythroid cell lines or iPSCs |
| Does a specific TPK1 mutation affect TPP synthesis? | Point-mutation knock-in of TPK1 in HEK293 cells; TPP quantification |
| Can overexpression of SLC19A3 rescue thiamine transport in neurons? | Overexpression of SLC19A3 in neuronal cell lines; uptake assays |
| What is the role of SLC25A19 in mitochondrial TPP import? | Knockout of SLC25A19 in HeLa cells; mitochondrial TPP measurement |
| Does tagged TPK1 localize to specific subcellular compartments? | Knock-in of fluorescent tag (e.g., GFP) at TPK1 locus; imaging |
| Can CRISPR activation of thiamine transporters improve thiamine status? | CRISPRa overexpression of SLC19A2/A3 in cell models; functional assays |
How to Study the thiamine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Determine if a gene is required for thiamine metabolism |
| CRISPR point mutation | Specific amino acid change | Model human disease variants in thiamine transporters or enzymes |
| CRISPR knock-in | Tagged or reporter gene | Study protein localization and dynamics |
| Overexpression | Increased gene dosage | Test sufficiency of a gene in thiamine metabolism |
| RNA-seq | Transcriptome changes | Identify pathways affected by thiamine perturbation |
| HPLC/mass spectrometry | Thiamine and TPP levels | Quantify thiamine metabolites in cells and tissues |
| Enzyme activity assays | TPP-dependent enzyme function | Assess metabolic impact of thiamine deficiency |
| CRISPR library screening | Genome-wide gene function | Identify modifiers of thiamine dependence |
Genetic and genomic methods
CRISPR-Cas9 knockout, point-mutation knock-in, and overexpression are powerful approaches to dissect the function of thiamine metabolic genes. RNA sequencing (RNA-seq) can reveal transcriptional changes in response to thiamine availability or genetic perturbation. Genome-wide CRISPR screens can identify genes that modify thiamine dependence or sensitivity to thiamine antagonists.
Biochemical and metabolic assays
Thiamine and its phosphorylated derivatives can be quantified by high-performance liquid chromatography (HPLC) or mass spectrometry. Enzyme activities of TPP-dependent enzymes, such as transketolase and pyruvate dehydrogenase, are measured spectrophotometrically. Thiamine transporter activity can be assessed using radiolabeled thiamine uptake assays in cell lines.
Imaging and localization
Fluorescently tagged thiamine transporters or TPP-binding proteins can be visualized by confocal microscopy to determine subcellular localization. Mitochondrial targeting of TPP carriers can be studied using mito-tracker dyes and co-localization analysis. Live-cell imaging of thiamine analogs can reveal real-time uptake and distribution.
Animal and plant models
Mouse models with knockout or knock-in of thiamine metabolic genes are used to study systemic effects on development, neurology, and metabolism. In plants, CRISPR editing of thiamine biosynthesis genes can improve biofortification and yield. Dairy cow models are used to study thiamine status and supplementation effects on rumen fermentation and health.
How CRISPR Can Be Used to Study GO:0006772 thiamine metabolic process
Knockout
CRISPR knockout of thiamine metabolic genes such as SLC19A2, SLC19A3, TPK1, or SLC25A19 in human cell lines can reveal their essential roles in thiamine uptake, TPP synthesis, and mitochondrial function. Knockout models are used to study the consequences of thiamine deficiency at the cellular level and to validate drug targets.
Point Mutation
Point mutations identified in patients with thiamine metabolism disorders can be introduced into cell lines using CRISPR prime editing or homology-directed repair to model disease-specific variants. These models help determine whether a variant is pathogenic and how it affects protein function, such as thiamine transport or TPP binding.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) or epitope tags at endogenous loci allows real-time visualization and biochemical purification of thiamine transporters and enzymes. Tagged knock-in models are valuable for studying protein localization, interactions, and dynamics in living cells.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase the expression of thiamine metabolic genes to test sufficiency in rescuing deficiency phenotypes or enhancing thiamine utilization. Overexpression models are also used to produce recombinant proteins for structural and biochemical studies.
How EDITGENE Supports thiamine metabolic process Research
Researchers studying thiamine metabolic process-related genes often need to determine whether a candidate gene is causally involved in thiamine uptake, TPP synthesis, or downstream metabolic effects. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation and accelerating therapeutic discovery.
Contact EDITGENE today to design your custom CRISPR model for thiamine metabolic process research.
Frequently Asked Questions About thiamine metabolic process
What is GO:0006772 thiamine metabolic process?
GO:0006772 is a Gene Ontology biological process term that describes all chemical reactions and pathways involving thiamine (vitamin B1), including its transport, phosphorylation to thiamine pyrophosphate (TPP), and degradation.
What genes are involved in thiamine metabolic process?
Key genes include SLC19A2, SLC19A3, SLC25A19, TPK1, and TPP1, as well as TPP-dependent enzymes such as PDHA1, OGDH, and TKT.
Why is thiamine metabolism important for human health?
Thiamine is essential for mitochondrial energy metabolism, and its deficiency causes beriberi and Wernicke-Korsakoff syndrome; genetic defects in thiamine transporters cause severe neurological and hematological disorders.
What diseases are associated with defects in thiamine metabolic process?
Diseases include thiamine-responsive megaloblastic anemia, biotin-responsive basal ganglia disease, Amish microcephaly, beriberi, and Wernicke-Korsakoff syndrome.
How is thiamine converted to its active form?
Thiamine is phosphorylated by thiamine pyrophosphokinase (TPK1) to thiamine pyrophosphate (TPP), the active coenzyme form.
What is the role of thiamine pyrophosphate (TPP) in metabolism?
TPP is a cofactor for enzymes such as pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase, which are involved in energy production and nucleotide synthesis.
How can CRISPR be used to study thiamine metabolism?
CRISPR knockout, point mutation, knock-in, and overexpression can be used to model gene function and disease variants in thiamine transporters and enzymes.
What are the symptoms of thiamine deficiency?
Symptoms include peripheral neuropathy, muscle weakness, heart failure, confusion, ataxia, and memory loss, as seen in beriberi and Wernicke-Korsakoff syndrome.
Which foods are rich in thiamine?
Thiamine is found in fresh vegetables, meats, especially liver, and whole grains; animal-derived foods generally have higher bioavailability than plant foods.
How is thiamine status measured in the laboratory?
Thiamine status can be assessed by measuring thiamine and its phosphate esters in blood or urine using HPLC or mass spectrometry, or by measuring transketolase activity in red blood cells.
Conclusion
GO:0006772 thiamine metabolic process is a fundamental biological process that encompasses the transport, phosphorylation, and utilization of vitamin B1. Its importance spans human health, where defects cause severe neurological and metabolic diseases, and agriculture, where biofortification and yield improvement are active goals. Advances in CRISPR genome editing and metabolic analytics now allow researchers to dissect the causal roles of individual genes in thiamine metabolism with unprecedented precision. Continued research into this pathway promises new insights into mitochondrial function, neurodegeneration, and nutritional interventions.
References
- 1. Chungchunlam SMS et al.. 2024. Comparative bioavailability of vitamins in human foods sourced from animals and plants.. Crit Rev Food Sci Nutr 64(31):11590-11625 PMID: 37522617
- 2. Depeint F et al.. 2006. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism.. Chem Biol Interact 163(1-2):94-112 PMID: 16765926
- 3. Luo Y et al.. 2025. Optimizing thiamine pyrophosphate metabolism enhances crop yield and quality.. Nat Commun 17(1):165 PMID: 41318547
- 4. Gregory JF 3rd. 1997. Bioavailability of Thiamin.. Eur J Clin Nutr 51 Suppl 1:S34-7 PMID: 9023478
- 5. Goyer A. 2017. Thiamin biofortification of crops.. Curr Opin Biotechnol 44:1-7 PMID: 27750185
- 6. Itokawa Y et al.. 1982. Thiamin-binding proteins.. Ann N Y Acad Sci 378:327-36 PMID: 7044227
- 7. Pan X et al.. 2018. Thiamine status, metabolism and application in dairy cows: a review.. Br J Nutr 120(5):491-499 PMID: 29986774
- 8. Brown G. 2014. Defects of thiamine transport and metabolism.. J Inherit Metab Dis 37(4):577-85 PMID: 24789339
